You are here

U.S. FDA panel unanimously votes in favor of RSV antibody treatment for infants

Primary tabs

The Food and Drug Administration’s (FDA) antimicrobial drug advisory panel on Thursday voted unanimously in favor of approving a respiratory syncytial virus (RSV) treatment for infants, bringing the product closer to approval following the overwhelming surge in RSV cases that were seen last year in young children.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
howdy folks
Page loaded in 0.391 seconds.